Global Influenza Vaccines Market Report 2022-2028: Increasing Government Support to Promote Influenza Vaccination and Rising Investments by Top Market…

Company Logo

Global Influenza Vaccines Market

Global Influenza Vaccines Market

Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, and Route of Administration" report has been added to ResearchAndMarkets.com's offering.

The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a CAGR of 7.4% from 2022 to 2028.

Increasing government support to promote influenza vaccination and rising investment by top market players and governments are the major factors boosting the market.

The governments of various states are supporting the promotional activities of vaccination program. For instance, the Australian government gives a free seasonal influenza vaccine to those at risk of influenza-related complications through the National Immunization Program (NIP). By 2022, enough vaccines have been given to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Vaccine Type Insights

Based on the vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment is likely to hold a larger market share in 2022.

The same segment is anticipated to register a higher CAGR during the forecast period. The quadrivalent influenza (flu) vaccine protects against 4 influenza viruses, including 2 influenza A viruses and 2 influenza B viruses. All flu vaccines in the US during the 2021-2022 season are quadrivalent vaccines. Different vaccines are approved for different age groups.

Virus Type Insights

Based on virus type, the influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the influenza virus type A segment is because it is the most common form of influenza and can infect animals, although illnesses associated with this type of flu are more common.

Technology Insights

Story continues

Based on technology, the influenza vaccines market is segmented into egg-based and cell-based. The egg-based segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period.

The market growth of the egg-based segment is due to its most common method of producing flu vaccines through an egg-based manufacturing process that has been used for more than 70 years.

Route of Administration Insights

Based on route of administration, the influenza vaccines market is segmented into injection and nasal spray. The injection segment is likely to hold a larger market share in 2022. The same segment is expected to register a higher CAGR during the forecast period.

The market growth of the injection segment is attributed to the fact that it is the most common method for flu vaccine administration.

Key Topics Covered:

1. Introduction

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

4. Influenza Vaccines Market - Market Landscape4.1 Overview4.2 PEST Analysis4.3 Experts Opinion

5. Global Influenza Vaccines Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increase in Government Support to Promote Influenza Vaccination5.1.2 Increasing Investment by Top Market Players and Governments5.2 Market Restraints5.2.1 High Cost of Vaccine Development5.3 Market Opportunities5.3.1 Emerging Economies5.4 Future Trends5.4.1 Strong Pipeline Candidates for Influenza Vaccines5.5 Impact Analysis

6. Influenza Vaccine Market -Global Analysis6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis6.2 Global Influenza Vaccines Market, By Geography - Forecasts And Analysis6.3 Global Influenza Vaccines Market - Market Potential Analysis, By Region6.4 Company Analysis6.4.1 Market Positioning of Key Players6.4.2 Comparative Company Analysis6.5 Growth Strategy Analysis6.6 Performance of Key Players6.6.1 Sanofi6.6.2 SEQIRUS

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type7.1 Overview7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)7.3 Quadrivalent Vaccines7.4 Trivalent Vaccines

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type8.1 Overview8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)8.3 Influenza Virus Type A8.4 Influenza Virus Type B

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology9.1 Overview9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)9.3 Egg-based9.4 Cell-based

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration10.1 Overview10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)10.3 Injection10.4 Nasal Spray

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

12. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

13. Influenza Vaccine Market -Industry Landscape13.1 Overview13.2 Growth Strategies in the Influenza Vaccine Market, 2021-202813.3 Inorganic Growth Strategies13.3.1 Overview13.4 Organic Growth Strategies13.4.1 Overview

14. Company Profiles14.1 Key Facts14.2 Business Description14.3 Products and Services14.4 Financial Overview14.5 SWOT Analysis14.6 Key Developments

Moderna, Inc.

SEQIRUS

Sanofi

GlaxoSmithKline plc.

Hualan Biological Engineering Inc.

Emergent BioSolutions Inc.

Mitsubishi Chemical Group Corporation

Serum Institute of India Pvt. Ltd

MYLAN N.V.

AstraZeneca

For more information about this report visit https://www.researchandmarkets.com/r/m3os4x

Attachment

Read more from the original source:

Global Influenza Vaccines Market Report 2022-2028: Increasing Government Support to Promote Influenza Vaccination and Rising Investments by Top Market...